Bausch & Lomb Inc, the eye care giant that announced plans early in May to sell itself to a private equity firm for US$65 a share, has received a competing offer of US$75 in cash and stock from Advanced Medical Optics Inc, Bausch announced on Thursday.
Because the new bid, valued at more than US$4 billion, contains a potentially volatile stock component of US$30 a share, it is not directly comparable with the original US$3.67 billion all-cash buyout offered by Warburg Pincus, the private equity firm.
In addition, a partial overlap in eye care products between Bausch, based in Rochester, New York, and Advanced Medical, based in Santa Ana, California, could raise antitrust questions and add uncertainty to how rapidly a deal could be completed.
As a result, analysts said, Warburg could still emerge as Bausch & Lomb's preferred suitor, with a sweetened offer in the US$70 to US$72 range. Bausch's shares, which closed on Tuesday before the Fourth of July holiday at US$68.64, fell as low as $67.66 early in the session on Thursday but later rose to US$72 before trading was halted when the Wall Street Journal reported the new offer online.
Advanced Medical's shares, by contrast, fell slightly after the news but before trading in its stock was halted. They ended higher for the day, at US$35.89, up from US$35.47 on Tuesday.
Advanced Medical's offer came on the last day in the 50-day period left by Bausch's agreement with Warburg allowing Bausch to solicit higher bids.
Although Advanced Medical had said in May that it was interested in acquiring Bausch, the offer came as a surprise to some analysts because Advanced Medical had subsequently been forced to undertake an expensive recall of Complete MoisturePlus, its leading contact lens solution, after an unusual number of users came down with eye infections.
Health regulators and the company are investigating the outbreak and Complete MoisturePlus' apparent links to it.
Last week, Advanced Medical told analysts it forecast a loss as high as US$1.15 a share on sales of US$1.05 billion to US$1.07 billion this year because of the recall, compared with its previous forecast of earnings up to US$1.55 a share on sales as high as US$1.18 billion.
Acquiring Bausch would help Advanced enter the market for contact lenses and give it a much stronger position in a better-known lens care solutions brand to go with its surgical implants and laser equipment.
However, Bausch's name in lens care has been tarnished by its own recall last year of ReNu With MoistureLoc, which was linked to an outbreak of fungal infections.
The provision that allowed Bausch to solicit Advanced Medical's bid is known as a go-shop provision. Go-shop provisions, aimed at ensuring that companies receive the highest possible price in a sale, have become increasingly popular but have rarely led to higher offers.
In Bausch's case, Advanced Medical may have been encouraged by the relatively low breakup fee in the Warburg deal. If Bausch ends up with another buyer, it must pay Warburg US$40 million, or about 1 percent of the transaction price. Such fees can run to 3 percent or higher.
ONGOING PROBE: A former Military Intelligence Bureau colonel, major general and another colonel, as well as five other people, have been questioned by prosecutors The Taipei District Court yesterday ordered that a retired colonel from the Military Intelligence Bureau (MIB) calling himself Taiwan’s “first special agent” be detained and held incommunicado as part of an ongoing investigation into espionage allegations targeting at least three former bureau officials. The Taipei District Prosecutors’ Office was seeking to detain former MIB colonel Chang Chao-jan (張超然) over his alleged involvement in introducing retired agents to Chinese national security authorities and passing confidential documents to China. Chang’s actions, if proven, would contravene the National Security Act (國家安全法), which carries a prison term of three to 10 years, and the National Intelligence
The US House of Representatives’ China Task Force, launched by Republicans earlier this year, yesterday proposed the China task force act, a package of 137 pieces of legislation, seven of which involve Taiwan, in the hope of getting it passed before the 117th US Congress convenes on Jan. 3. The act encompasses a wide range of issues, including combatting Beijing’s influence around the globe, establishing the US’ dominance in determining 5G network standards and means for bringing UN members to task for abusing their influence within the UN system. The seven acts involving Taiwan address concerns such as the Taiwan Assurance Act
Chinese health authorities investigating a COVID-19 outbreak have said that they discovered live coronavirus on frozen food packaging, a finding that suggests the virus can survive in cold supply chains. The Chinese Center for Disease Control and Prevention on Saturday said that it had found traces of live COVID-19 on the outer packaging of frozen cod in the eastern city of Qingdao, marking the first time that live coronavirus has been detected on the outside of refrigerated goods. Researchers were investigating the source of a cluster of cases linked to a hospital in Qingdao. Genetic traces had previously been found in samples of
A Chinese soldier apprehended earlier this week by the Indian Army after he strayed across a tense de facto border was on Tuesday night handed back to China, an Indian government source in New Delhi said yesterday. The Chinese People’s Liberation Army (PLA) soldier had on Monday been captured in the Demchok area of eastern Ladakh, the Indian Army said in a statement. The Chinese military also released a statement, saying that Corporal Wang Yalong was handed over early yesterday. New Delhi on Monday said that it had detained Wang after he crossed into Indian-controlled territory, while China announced that Wang had gotten